CLINICAL_TRIALS
trial_result
· 2022-02-09
Clinical Trial Update: Combination Therapy With 3BNC117 and 10-1074 in HIV-Infected Individuals [Phase 1]
Summary
Phase 1 trial evaluating combination therapy with 3BNC117 and 10-1074 in HIV-infected individuals was terminated; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 1 | Status: TERMINATED | Results posted: 2022-02-09